000144528 001__ 144528
000144528 005__ 20230915101354.0
000144528 0247_ $$2doi$$a10.1182/blood-2018-99-114675
000144528 0247_ $$2ISSN$$a0006-4971
000144528 0247_ $$2ISSN$$a1528-0020
000144528 037__ $$aDZNE-2020-00065
000144528 082__ $$a610
000144528 1001_ $$aPoschmann, Linda$$b0
000144528 1112_ $$a60th American Society of Hematology Annual Meeting$$cSan Diego, CA$$d2018-12-01 - 2018-12-04$$wUSA
000144528 245__ $$aIn Vivo Blockade of Beta-1 and Beta-2 Integrin Activity Inhibits Splenomegaly in JAK2-V617F Positive Myeloproliferative Disease
000144528 260__ $$c2018
000144528 264_1 $$2Crossref$$3print$$bAmerican Society of Hematology$$c2018-11-29
000144528 3367_ $$033$$2EndNote$$aConference Paper
000144528 3367_ $$2BibTeX$$aINPROCEEDINGS
000144528 3367_ $$2DRIVER$$aconferenceObject
000144528 3367_ $$2ORCID$$aCONFERENCE_POSTER
000144528 3367_ $$2DataCite$$aOutput Types/Conference Poster
000144528 3367_ $$0PUB:(DE-HGF)24$$2PUB:(DE-HGF)$$aPoster$$bposter$$mposter$$s1590658990_3565$$xOther
000144528 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x0
000144528 588__ $$aDataset connected to CrossRef
000144528 7001_ $$aEdelmann-Stephan, Bärbel$$b1
000144528 7001_ $$aMüller, Peter$$b2
000144528 7001_ $$0P:(DE-2719)2810456$$aAngenstein, Frank$$b3$$udzne
000144528 7001_ $$0P:(DE-HGF)0$$aFischer, Thomas$$b4
000144528 77318 $$2Crossref$$3journal-article$$a10.1182/blood-2018-99-114675$$b : American Society of Hematology, 2018-11-29$$nSupplement 1$$p1778-1778$$tBlood$$v132$$x0006-4971$$y2018
000144528 773__ $$0PERI:(DE-600)1468538-3$$a10.1182/blood-2018-99-114675$$gVol. 132, no. Supplement 1, p. 1778 - 1778$$nSupplement 1$$p1778-1778$$tBlood$$v132$$x0006-4971$$y2018
000144528 909CO $$ooai:pub.dzne.de:144528$$pVDB
000144528 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810456$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000144528 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$aDE-HGF$$bForschungsbereich Gesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x0
000144528 9141_ $$y2018
000144528 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-11
000144528 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-01-11
000144528 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBLOOD : 2021$$d2022-11-25
000144528 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-25
000144528 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-25
000144528 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-25
000144528 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-25
000144528 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-25
000144528 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-25
000144528 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-25
000144528 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-25
000144528 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-25
000144528 915__ $$0StatID:(DE-HGF)9925$$2StatID$$aIF >= 25$$bBLOOD : 2021$$d2022-11-25
000144528 9201_ $$0I:(DE-2719)1310004$$kAG Angenstein$$lFunctional Neuroimaging$$x0
000144528 980__ $$aposter
000144528 980__ $$aVDB
000144528 980__ $$aI:(DE-2719)1310004
000144528 980__ $$aUNRESTRICTED